Drug intelligence / Profile preview

Compound Danshen Dropping Pill

Development stage
Unknown
Lead developer
Tasly Holding Group
Modality
Small Molecules
Administration
Oral, Sublingual
01

Overview

Compound Danshen Dropping Pill (CDDP) is a traditional Chinese patent medicine formulation primarily composed of extracts from *Salvia miltiorrhiza* (Danshen), *Panax notoginseng* (Sanqi), and Borneol. It is widely used in China for the treatment of cardiovascular diseases, particularly coronary heart disease (CHD) and angina pectoris. The formulation exerts its therapeutic effects through multiple pathways, including antiplatelet aggregation, anti-inflammatory actions, and protection of the vascular endothelium. Clinical research, including studies conducted at West China Hospital, has evaluated its impact on heart and artery structure and function in patients with comorbid CHD and hypertension. It is manufactured as a dropping pill, which allows for both oral and sublingual administration.

Brand names
Compound Danshen Dropping Pill
Other names
Danshen Dripping PillFufang Danshen Diwan
02

Targets

BCL-2 (BCL-2 family)VEGFA (Vascular endothelial growth factor A)SCN5A (Sodium channel protein type 5 subunit alpha)

Beyond the preview

Go deeper on Compound Danshen Dropping Pill.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Compound Danshen Dropping Pill.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call